Furiex Pharmaceuticals, Inc. is a drug development collaboration company using innovative clinical development design to accelerate and increase the value of partnered drug programs by advancing them to the market in a cost-efficient manner.
EXPERT. FOCUSED. FAST.
14 May >> Furiex Pharmaceuticals and Menarini Announce License Agreement for Priligy® More details >
14 May >> Furiex Pharmaceuticals Announces Agreement to Transfer Priligy® Product Rights More details >
03 May >> Furiex Reports First Quarter 2012 Financial Results More details >